Hughes Steven George
Insider CIK 1747528 · ONVO Chief Medical Officer · RNA Chief Medical Officer · ARCT Chief Development Officer · RNA Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNA Atrium Therapeutics, Inc. | F Tax w/h | 2026-09-18 | 2026-09-22 | 21,459 | $8.95 | $192.1K | 51,638 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | F Tax w/h | 2026-09-18 | 2026-09-22 | 21,459 | $8.95 | $192.1K | 51,638 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award deriv | 2026-04-20 | 2026-04-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award | 2026-04-20 | 2026-04-22 | 30,000 | — | $0 | 73,097 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 74,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 49,333 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 68,458 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 73,342 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 50,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 115,857 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-21 | 2026-01-23 | 2,878 | $72.45 | $208.5K | 31,599 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-21 | 2026-01-23 | 2,017 | $72.45 | $146.1K | 34,477 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 2,373 | $72.23 | $171.4K | 36,494 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-10-22 | 2025-10-24 | 2,209 | — | $0 | 68,458 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-10-22 | 2025-10-24 | 2,209 | $10.16 | $22.4K | 41,076 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-10-22 | 2025-10-24 | 2,209 | $47.54 | $105.0K | 38,867 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-09-22 | 2025-09-23 | 2,208 | — | $0 | 70,667 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-09-22 | 2025-09-23 | 2,208 | $10.16 | $22.4K | 41,075 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-22 | 2025-09-23 | 2,208 | $40.58 | $89.6K | 38,867 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-09-15 | 2025-09-17 | 1,542 | — | $0 | 49,333 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-09-15 | 2025-09-17 | 1,542 | $6.57 | $10.1K | 40,409 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-15 | 2025-09-17 | 1,542 | $45.41 | $70.0K | 38,867 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-22 | 2025-08-22 | 2,208 | — | $0 | 72,875 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-22 | 2025-08-22 | 2,208 | $46.40 | $102.5K | 38,867 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-22 | 2025-08-22 | 2,208 | $10.16 | $22.4K | 41,075 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-13 | 2025-08-15 | 1,542 | — | $0 | 50,875 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-13 | 2025-08-15 | 1,542 | $46.66 | $71.9K | 38,867 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-13 | 2025-08-15 | 1,542 | $6.57 | $10.1K | 40,409 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 17,667 | — | $0 | 75,083 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 6,167 | — | $0 | 74,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 12,334 | — | $0 | 52,417 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 11,283 | — | $0 | 73,342 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 17,667 | $10.16 | $179.5K | 90,517 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 6,167 | $42.74 | $263.6K | 72,850 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 6,167 | $22.47 | $138.6K | 79,017 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 12,334 | $42.74 | $527.2K | 72,850 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 12,334 | $6.57 | $81.0K | 85,184 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 11,283 | $42.74 | $482.2K | 72,850 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 11,283 | $15.96 | $180.1K | 84,133 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 33,983 | $42.74 | $1.45M | 38,867 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 17,667 | $42.74 | $755.1K | 72,850 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 9,578 | $31.06 | $297.5K | 72,850 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 1,915 | $28.60 | $54.8K | 84,460 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 2,032 | $28.59 | $58.1K | 82,428 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 86,375 | SEC↗ |
| ARCT Arcturus Therapeutics Hold | A Award deriv | 2020-12-18 | 2020-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARCT Arcturus Therapeutics Hold | A Award deriv | 2020-02-18 | 2020-02-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | S Sale | 2019-08-16 | 2019-08-19 | 22,230 | $0.29 | $6.4K | 138,484 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | A Award deriv | 2018-08-14 | 2018-08-15 | 974,694 | — | $0 | 974,694 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | A Award | 2018-08-14 | 2018-08-15 | 160,714 | — | $0 | 160,714 | SEC↗ |